CHRISTY GREEN: Open Payments
NPI 1992354906 · JASPER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 25 payments from 13 companies in 2025. Trend: 2023 $307 · 2024 $582 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Lilly USA, LLC | 3 | $55 |
| ABBVIE INC. | 3 | $54 |
| Astellas Pharma US Inc | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Veozah, Wegovy, MOUNJARO, Kerendia, Ozempic.
Industry payments across TN — which companies pay providers there.
